D-1085-2023 Class III Terminated

Recalled by Advanced Accelerator Applications USA, Inc. — Millburn, NJ

FDA drug recall D-1085-2023 was initiated by Advanced Accelerator Applications USA, Inc. on Aug 7, 2023 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Lot and/or Exp Date: vials were labeled with the incorrect lot number and expiration date The recall status is terminated (terminated Mar 12, 2024). Affected quantity: 10.

Recall details

Product Type
Drugs
Report Date
Aug 23, 2023
Initiation Date
Aug 7, 2023
Termination Date
Mar 12, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
10

Product description

PLUVICTO 1,000MBq/mL (27 mCi/mL), lutetium Lu 177 vipivotide tetraxetan injection, 9.2 mL Single-dose vial, Manufacturer: Advanced Accelerator Appllications USA, Inc., 57 E. Willow Street NJ 07041, Milburn, USA, NDC 69488-010-61

Reason for recall

Labeling: Incorrect or Missing Lot and/or Exp Date: vials were labeled with the incorrect lot number and expiration date

Distribution pattern

Distributed Nationwide in the USA

Code information

Lot # LPS230729B-16, Exp 8/3/2023 at 10:00am, LPS230804B-16, Exp 8/9/2023 at 10:00am.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1085-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1085-2023. Report a data issue: hello@regdatalab.com.